Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation
Authors:
- A.A. BaranovABA.A. Baranov
- A.G. BadoyanABA.G. Badoyan
- D.A. KhelimskiyDKD.A. Khelimskiy
- A.YU. CydenovaACA.YU. Cydenova
- R.A. NaydenovRNR.A. Naydenov
- V.A. BoboshkoVBV.A. Boboshko
- V.V. LomivorotovVLV.V. Lomivorotov
- V.B. ArutyunyanVAV.B. Arutyunyan
- B.K. KadyralievBKB.K. Kadyraliev
- O.V. KrestyaninovOKO.V. Krestyaninov
- 22 April 2024
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 17 (5)
Abstract
Objective. To determine the factors associated with periprocedural increase in high-sensitive troponin I (hsTrI) after transcatheter aortic valve implantation (TAVI), as well as to evaluate prognostic significance of periprocedural myocardial injury (PMI) on survival of patients after TAVI. Material and methods. A retrospective study included 149 patients who underwent TAVI for severe aortic stenosis. Analysis included patients with available assessment of hsTrI before and after TAVI. According to postoperative hsTrI (VARC-3 criteria), all patients were divided into 2 groups: group 1 — patients with 70 times excess of the upper limit of normal (ULN) hsTrI («hsTrI≥70×ULN»), group 2 — patients with hsTrI <70xULN («hsTrI<70×ULN»). Results. PMI occurred in 18.8% of patients. According to multivariate regression analysis, independent predictors of 70-fold increase in hsTrI were age (OR 1.13, 95% CI 1.01—1.26, p=0.03), female sex (OR 15.6, 95% CI 2.57—95.20, p=0.003) and bioprosthesis implantation depth (OR 1.46, 95% CI 1.10—1.94, p=0.009). There were no significant differences in survival rate (85.7% vs. 90.9%, plog-rank=0.48). Conclusion. Age, female gender and bioprosthesis implantation depth were independent predictors of PMI after TAVI. Myocardial injury after TAVI does not affect long-term survival of patients.Keywords
This publication has 32 references indexed in Scilit:
- Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacementHeart and Vessels, 2021
- Correlates and Significance of Elevation of Cardiac Biomarkers Elevation Following Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2017
- Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2017
- Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2015
- Detection of Myocardial Injury by CMR After Transcatheter Aortic Valve ReplacementJACC, 2014
- Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary RevascularizationJACC, 2013
- 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve ReplacementJACC, 2012
- Incidence, Predictive Factors, and Prognostic Value of Myocardial Injury Following Uncomplicated Transcatheter Aortic Valve ImplantationJACC, 2011
- Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical TrialsJACC, 2011
- The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 1—Coronary Artery Bypass Grafting SurgeryThe Annals of Thoracic Surgery, 2009